Stay updated on Apitegromab Long-Term Safety & Efficacy in SMA Clinical Trial
Sign up to get notified when there's something new on the Apitegromab Long-Term Safety & Efficacy in SMA Clinical Trial page.

Latest updates to the Apitegromab Long-Term Safety & Efficacy in SMA Clinical Trial page
- Check6 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check13 days agoChange DetectedA site-wide NIH notice announces transition updates and says federal agencies are using “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI).SummaryDifference0.5%

- Check20 days agoChange DetectedThe ClinicalTrials.gov site footer revision changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check27 days agoChange DetectedThe ClinicalTrials.gov footer revision changes from v3.7.0 to v3.7.1, with no change to the study record content.SummaryDifference0.1%

- Check48 days agoChange DetectedThis update adds the latest revision entry labeled v3.7.0 to the study record history and removes the previous v3.6.6 entry, reflecting an update to the page's version history.SummaryDifference0.1%

- Check62 days agoChange DetectedContacts/Locations and Study Status sections were added to the study history, updating the record with current contact details, locations, and recruitment status. The history entry dated 2025-05-25 was removed.SummaryDifference0.4%

Stay in the know with updates to Apitegromab Long-Term Safety & Efficacy in SMA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Apitegromab Long-Term Safety & Efficacy in SMA Clinical Trial page.